Literature DB >> 26256124

Adverse reactions to snake antivenom, and their prevention and treatment.

H Asita de Silva1, Nicole M Ryan2, H Janaka de Silva1.   

Abstract

Antivenom is the mainstay of treatment of snakebite envenoming. However, adverse reactions to snake antivenom that is available are common in many parts of the world where snakebite is prevalent. Both acute (anaphylactic or pyrogenic) and delayed (serum sickness type) reactions occur. Acute reactions are usually mild but severe systemic anaphylaxis may develop, often within an hour or so of exposure to antivenom. Serum sickness after antivenom has a delayed onset between 5 and 14 days after its administration. Ultimately, the prevention reactions will depend mainly on improving the quality of antivenom. Until these overdue improvements take place, doctors will have to depend on pharmacological prophylaxis, where the search for the best prophylactic agent is still on-going, as well as careful observation of patients receiving antivenom in preparation for prompt management of acute as well as delayed reactions when they occur.
© 2015 The British Pharmacological Society.

Entities:  

Keywords:  acute reactions; antivenom reactions; prophylaxis; serum; snakebite envenoming

Mesh:

Substances:

Year:  2015        PMID: 26256124      PMCID: PMC4767202          DOI: 10.1111/bcp.12739

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  47 in total

Review 1.  Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms.

Authors:  Guillermo León; María Herrera; Álvaro Segura; Mauren Villalta; Mariángela Vargas; José María Gutiérrez
Journal:  Toxicon       Date:  2013-09-20       Impact factor: 3.033

Review 2.  Anaphylaxis: mechanisms and management.

Authors:  J K Lee; P Vadas
Journal:  Clin Exp Allergy       Date:  2011-07       Impact factor: 5.018

3.  Antivenene in the treatment of Australian and Papuan snake bite.

Authors:  C H Campbell
Journal:  Med J Aust       Date:  1967-07-15       Impact factor: 7.738

4.  Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bites.

Authors:  H W Fan; L F Marcopito; J L Cardoso; F O França; C M Malaque; R A Ferrari; R D Theakston; D A Warrell
Journal:  BMJ       Date:  1999-05-29

5.  Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite.

Authors:  Eric J Lavonas; Jamie Kokko; Tammi H Schaeffer; Sara L Mlynarchek; Gregory M Bogdan; Richard C Dart
Journal:  Ann Emerg Med       Date:  2010-10-16       Impact factor: 5.721

6.  Serum reactions. An analysis of commercial antivenoms and the possible role of anticomplementary activity in de-novo reactions to antivenoms and antitoxins.

Authors:  S K Sutherland
Journal:  Med J Aust       Date:  1977-04-23       Impact factor: 7.738

7.  Serum sickness following administration of Antivenin (Crotalidae) Polyvalent in 181 cases of presumed rattlesnake envenomation.

Authors:  Frank LoVecchio; Jane Klemens; Elizabeth BoAnn Roundy; Annie Klemens
Journal:  Wilderness Environ Med       Date:  2003       Impact factor: 1.518

8.  Delayed psychological morbidity associated with snakebite envenoming.

Authors:  Shehan S Williams; Chamara A Wijesinghe; Shaluka F Jayamanne; Nicholas A Buckley; Andrew H Dawson; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2011-08-02

9.  Confronting the neglected problem of snake bite envenoming: the need for a global partnership.

Authors:  José María Gutiérrez; R David G Theakston; David A Warrell
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

10.  Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial.

Authors:  H Asita de Silva; Arunasalam Pathmeswaran; Channa D Ranasinha; Shaluka Jayamanne; Senarath B Samarakoon; Ariyasena Hittharage; Ranjith Kalupahana; G Asoka Ratnatilaka; Wimalasiri Uluwatthage; Jeffrey K Aronson; Jane M Armitage; David G Lalloo; H Janaka de Silva
Journal:  PLoS Med       Date:  2011-05-10       Impact factor: 11.069

View more
  51 in total

Review 1.  Adverse reactions to snake antivenom, and their prevention and treatment.

Authors:  H Asita de Silva; Nicole M Ryan; H Janaka de Silva
Journal:  Br J Clin Pharmacol       Date:  2015-09-16       Impact factor: 4.335

2.  Bungarus multicinctus multicinctus Snakebite in Taiwan.

Authors:  Yan-Chiao Mao; Po-Yu Liu; Liao-Chun Chiang; Shu-Chen Liao; Hung-Yuan Su; Szu-Yin Hsieh; Chen-Chang Yang
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

Review 3.  Distinct antibody species: structural differences creating therapeutic opportunities.

Authors:  Serge Muyldermans; Vaughn V Smider
Journal:  Curr Opin Immunol       Date:  2016-02-27       Impact factor: 7.486

4.  Therapeutics in clinical toxicology: in the absence of strong evidence how do we choose between antidotes, supportive care and masterful inactivity.

Authors:  Geoffrey K Isbister; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2016-03       Impact factor: 4.335

5.  Accuracy of the Lee-White Clotting Time Performed in the Hospital Routine to Detect Coagulopathy in Bothrops atrox Envenomation.

Authors:  Jose Diego de Brito Sousa; Jacqueline Almeida Gonçalves Sachett; Sâmella Silva de Oliveira; Iran Mendonça-da-Silva; Hedylamar Oliveira Marques; Marcus Vinicius Guimarães de Lacerda; Hui Wen Fan; Wuelton Marcelo Monteiro
Journal:  Am J Trop Med Hyg       Date:  2018-03-29       Impact factor: 2.345

Review 6.  The management of a blood donor bitten by a snake.

Authors:  Giuseppe Marano; Massimo Franchini; Liviana Catalano; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno
Journal:  Ann Transl Med       Date:  2017-12

7.  Process for production and purification of Lethal Toxin Neutralizing Factor (LTNF) from E. coli and its economic analysis.

Authors:  Vishwanath Hebbi; P Kathiresan; Devendra Kumar; Claire Komives; Anurag S Rathore
Journal:  J Chem Technol Biotechnol       Date:  2017-12-05       Impact factor: 3.174

Review 8.  Who gets antidotes? choosing the chosen few.

Authors:  Nicholas A Buckley; Andrew H Dawson; David N Juurlink; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2016-02-17       Impact factor: 4.335

Review 9.  Managing snakebite.

Authors:  Ravikar Ralph; Mohammad Abul Faiz; Sanjib Kumar Sharma; Isabela Ribeiro; François Chappuis
Journal:  BMJ       Date:  2022-01-07

10.  Aqueous Leaf Extract of Jatropha mollissima (Pohl) Bail Decreases Local Effects Induced by Bothropic Venom.

Authors:  Jacyra Antunes Dos Santos Gomes; Juliana Félix-Silva; Júlia Morais Fernandes; Juliano Geraldo Amaral; Norberto Peporine Lopes; Eryvaldo Sócrates Tabosa do Egito; Arnóbio Antônio da Silva-Júnior; Silvana Maria Zucolotto; Matheus de Freitas Fernandes-Pedrosa
Journal:  Biomed Res Int       Date:  2016-10-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.